We are live on ! Find out more
AF

Avanza Fonder Portfolio holdings

AUM $4.59B
1-Year Est. Return 41.03%
This Fund
S&P 500
This Quarter Est. Return
-4.89%
1 Year Est. Return
+41.03%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.05B
AUM Growth
-$320M
Cap. Flow
-$135M
Cap. Flow %
-4.44%
Top 10 Hldgs %
40.33%
Holding
468
New
31
Increased
49
Reduced
321
Closed
8

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$20.2M
2
ACN icon
Accenture
ACN
+$14.8M
3
MDT icon
Medtronic
MDT
+$11M
4
CB icon
Chubb
CB
+$7.13M
5
TT icon
Trane Technologies
TT
+$7.1M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$21.5M
2
NVDA icon
NVIDIA
NVDA
+$19.3M
3
AMZN icon
Amazon
AMZN
+$14.6M
4
AAPL icon
Apple
AAPL
+$11.2M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.05M

Sector Composition

Rank Sector Weight
1 Technology 34.06%
2 Consumer Discretionary 14.72%
3 Financials 13.56%
4 Healthcare 12.28%
5 Communication Services 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMD icon
26
Advanced Micro Devices
AMD
$791B
$16.2M 0.53%
157,176
-24,316
-13% -$2.7M
QCOM icon
27
Qualcomm
QCOM
$160B
$15.4M 0.51%
99,888
-12,627
-11% -$2.06M
AMGN icon
28
Amgen
AMGN
$209B
$15.3M 0.5%
50,148
-8,974
-15% -$2.65M
CRM icon
29
Salesforce
CRM
$148B
$15.2M 0.5%
56,117
-6,872
-11% -$2.14M
BSX icon
30
Boston Scientific
BSX
$68.4B
$14.7M 0.48%
146,447
-14,924
-9% -$1.5M
IBM icon
31
IBM
IBM
$209B
$14.5M 0.48%
58,118
-8,567
-13% -$2.1M
MCD icon
32
McDonald's
MCD
$191B
$14.4M 0.47%
46,098
-5,932
-11% -$1.77M
RY icon
33
Royal Bank of Canada
RY
$292B
$13.9M 0.46%
84,690
-8,000
-9% -$942K
SYK icon
34
Stryker
SYK
$133B
$13.7M 0.45%
36,391
-4,790
-12% -$1.82M
T icon
35
AT&T
T
$159B
$13.4M 0.44%
475,835
-42,183
-8% -$1.06M
GILD icon
36
Gilead Sciences
GILD
$163B
$13.4M 0.44%
119,661
-7,454
-6% -$769K
GS icon
37
Goldman Sachs
GS
$302B
$13.4M 0.44%
23,748
+244
+1% +$147K
TJX icon
38
TJX Companies
TJX
$176B
$13.3M 0.43%
106,096
-7,706
-7% -$935K
ACN icon
39
Accenture
ACN
$99.9B
$13.2M 0.43%
+41,798
New +$14.8M
DIS icon
40
Walt Disney
DIS
$167B
$13.2M 0.43%
134,672
-1,160
-0.9% -$125K
PFE icon
41
Pfizer
PFE
$142B
$13.1M 0.43%
531,062
-66,648
-11% -$1.74M
TMO icon
42
Thermo Fisher Scientific
TMO
$214B
$12.8M 0.42%
26,200
-3,714
-12% -$2.01M
LOW icon
43
Lowe's Companies
LOW
$118B
$12.7M 0.42%
54,013
-3,169
-6% -$780K
VZ icon
44
Verizon
VZ
$193B
$12.7M 0.42%
283,197
-40,932
-13% -$1.7M
PGR icon
45
Progressive
PGR
$124B
$12M 0.39%
42,682
-5,194
-11% -$1.36M
DE icon
46
Deere & Co
DE
$162B
$11.8M 0.39%
24,962
-1,311
-5% -$613K
VRTX icon
47
Vertex Pharmaceuticals
VRTX
$122B
$11.6M 0.38%
24,020
-4,138
-15% -$1.93M
AXP icon
48
American Express
AXP
$228B
$11.6M 0.38%
42,055
+1,344
+3% +$397K
AMAT icon
49
Applied Materials
AMAT
$398B
$11.5M 0.38%
78,117
-7,090
-8% -$1.19M
BMY icon
50
Bristol-Myers Squibb
BMY
$132B
$11.4M 0.38%
192,034
-26,192
-12% -$1.53M

Similar funds

Avanza Fonder's Q1 2025 Portfolio in Review

As of Q1 2025, Avanza Fonder held 468 positions worth $3.05B, down 9.5% from $3.37B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Avanza Fonder withdrew a net $135M in Q1 2025, closing 8 positions and reducing 321 holdings. Its most notable exit was SoFi Technologies, an estimated $1.01M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Avanza Fonder opened a new position in Linde worth $21.1M.

  • Avanza Fonder's largest Q1 2025 buy was Linde: 44,860 shares worth $21.1M.
  • Avanza Fonder added most to Tesla in Q1 2025, an estimated $3.07M increase.
  • Avanza Fonder's biggest Q1 2025 reduction was Microsoft, cutting an estimated $21.5M.
  • Avanza Fonder fully exited SoFi Technologies in Q1 2025, selling an estimated $1.01M.
  • Avanza Fonder's ten largest holdings make up 40% of its $3.05B portfolio in Q1 2025.
  • Avanza Fonder opened 31 new positions and closed 8 in Q1 2025.
  • Avanza Fonder's portfolio value fell 9.5% quarter-over-quarter to $3.05B.

Based on Avanza Fonder's 13F filing for Q1 2025, filed 15 Apr 2025.